102 related articles for article (PubMed ID: 34015430)
1. Relationship between anti-fungal effects and lung exposure of PC945, a novel inhaled antifungal agent, in Aspergillus fumigatus infected mice: Pulmonary PK-PD analysis of anti-fungal PC945.
Ito K; Kizawa Y; Kimura G; Nishimoto Y; Daly L; Knowles I; Hows M; Ayrton J; Strong P
Eur J Pharm Sci; 2021 Aug; 163():105878. PubMed ID: 34015430
[TBL] [Abstract][Full Text] [Related]
2.
Kimura G; Nakaoki T; Colley T; Rapeport G; Strong P; Ito K; Kizawa Y
Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28630185
[TBL] [Abstract][Full Text] [Related]
3.
Colley T; Alanio A; Kelly SL; Sehra G; Kizawa Y; Warrilow AGS; Parker JE; Kelly DE; Kimura G; Anderson-Dring L; Nakaoki T; Sunose M; Onions S; Crepin D; Lagasse F; Crittall M; Shannon J; Cooke M; Bretagne S; King-Underwood J; Murray J; Ito K; Strong P; Rapeport G
Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28223388
[TBL] [Abstract][Full Text] [Related]
4. PC945, a Novel Inhaled Antifungal Agent, for the Treatment of Respiratory Fungal Infections.
Murray A; Cass L; Ito K; Pagani N; Armstrong-James D; Dalal P; Reed A; Strong P
J Fungi (Basel); 2020 Dec; 6(4):. PubMed ID: 33348852
[TBL] [Abstract][Full Text] [Related]
5. Antifungal synergy of a topical triazole, PC945, with a systemic triazole against respiratory Aspergillus fumigatus infection.
Colley T; Sehra G; Daly L; Kimura G; Nakaoki T; Nishimoto Y; Kizawa Y; Strong P; Rapeport G; Ito K
Sci Rep; 2019 Jul; 9(1):9482. PubMed ID: 31263150
[TBL] [Abstract][Full Text] [Related]
6. Effects of intranasally dosed posaconazole on fungal load and biomarkers in Aspergillus fumigatus infected immunocompromised mice.
Kimura G; Nakaoki T; Nishimoto Y; Suzuki Y; Rapeport G; Strong P; Ito K; Kizawa Y
Mycoses; 2017 Nov; 60(11):728-735. PubMed ID: 28699245
[TBL] [Abstract][Full Text] [Related]
7. [Comparison of glucan and galactomannan tests with real-time PCR for diagnosis of invasive aspergillosis in a neutropenic rat model].
Aydoğan S; Kuştimur S; Kalkancı A
Mikrobiyol Bul; 2010 Jul; 44(3):441-52. PubMed ID: 21063994
[TBL] [Abstract][Full Text] [Related]
8. Safety and nonclinical and clinical pharmacokinetics of PC945, a novel inhaled triazole antifungal agent.
Cass L; Murray A; Davis A; Woodward K; Albayaty M; Ito K; Strong P; Ayrton J; Brindley C; Prosser J; Murray J; French E; Haywood P; Wallis C; Rapeport G
Pharmacol Res Perspect; 2021 Feb; 9(1):e00690. PubMed ID: 33340279
[TBL] [Abstract][Full Text] [Related]
9.
Colley T; Sehra G; Chowdhary A; Alanio A; Kelly SL; Kizawa Y; Armstrong-James D; Fisher MC; Warrilow AGS; Parker JE; Kelly DE; Kimura G; Nishimoto Y; Sunose M; Onions S; Crepin D; Lagasse F; Crittall M; Shannon J; McConville M; King-Underwood J; Naylor A; Bretagne S; Murray J; Ito K; Strong P; Rapeport G
Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29439966
[TBL] [Abstract][Full Text] [Related]
10. Characterization and comparison of galactomannan enzyme immunoassay and quantitative real-time PCR assay for detection of Aspergillus fumigatus in bronchoalveolar lavage fluid from experimental invasive pulmonary aspergillosis.
Francesconi A; Kasai M; Petraitiene R; Petraitis V; Kelaher AM; Schaufele R; Hope WW; Shea YR; Bacher J; Walsh TJ
J Clin Microbiol; 2006 Jul; 44(7):2475-80. PubMed ID: 16825367
[TBL] [Abstract][Full Text] [Related]
11. Pharmacodynamics of the Orotomides against
Hope WW; McEntee L; Livermore J; Whalley S; Johnson A; Farrington N; Kolamunnage-Dona R; Schwartz J; Kennedy A; Law D; Birch M; Rex JH
mBio; 2017 Aug; 8(4):. PubMed ID: 28830945
[TBL] [Abstract][Full Text] [Related]
12. Antifungal efficacy of caspofungin (MK-0991) in experimental pulmonary aspergillosis in persistently neutropenic rabbits: pharmacokinetics, drug disposition, and relationship to galactomannan antigenemia.
Petraitiene R; Petraitis V; Groll AH; Sein T; Schaufele RL; Francesconi A; Bacher J; Avila NA; Walsh TJ
Antimicrob Agents Chemother; 2002 Jan; 46(1):12-23. PubMed ID: 11751105
[TBL] [Abstract][Full Text] [Related]
13. Anti-fungal activity of a novel triazole, PC1244, against emerging azole-resistant Aspergillus fumigatus and other species of Aspergillus.
Colley T; Sharma C; Alanio A; Kimura G; Daly L; Nakaoki T; Nishimoto Y; Bretagne S; Kizawa Y; Strong P; Rapeport G; Ito K; Meis JF; Chowdhary A
J Antimicrob Chemother; 2019 Oct; 74(10):2950-2958. PubMed ID: 31361006
[TBL] [Abstract][Full Text] [Related]
14. Detection of Aspergillus fumigatus-specific DNA, (1-3)-beta-D-glucan and galactomannan in serum and bronchoalveolar lavage specimens of experimentally infected rats.
Khan ZU; Ahmad S; Theyyathel AM
Mycoses; 2008 Mar; 51(2):129-35. PubMed ID: 18254749
[TBL] [Abstract][Full Text] [Related]
15. Performance of the AsperGenius® PCR assay for detecting azole resistant Aspergillus fumigatus in BAL fluids from allogeneic HSCT recipients: A prospective cohort study from Essen, West Germany.
Pelzer BW; Seufert R; Koldehoff M; Liebregts T; Schmidt D; Buer J; Rath PM; Steinmann J
Med Mycol; 2020 Feb; 58(2):268-271. PubMed ID: 31111913
[TBL] [Abstract][Full Text] [Related]
16. [The expression of triggering receptor expressed on myeloid cells receptor-1 in Aspergillus infected mice].
Cui N; Wang H; Su LX; Zhang JH; Liu DW
Zhonghua Nei Ke Za Zhi; 2017 Aug; 56(8):601-605. PubMed ID: 28789494
[No Abstract] [Full Text] [Related]
17. Pharmacodynamics of Posaconazole in Experimental Invasive Pulmonary Aspergillosis: Utility of Serum Galactomannan as a Dynamic Endpoint of Antifungal Efficacy.
Gastine S; Hope W; Hempel G; Petraitiene R; Petraitis V; Mickiene D; Bacher J; Walsh TJ; Groll AH
Antimicrob Agents Chemother; 2021 Jan; 65(2):. PubMed ID: 33168606
[No Abstract] [Full Text] [Related]
18. Galactomannan testing in bronchoalveolar lavage fluid facilitates the diagnosis of invasive pulmonary aspergillosis in patients with hematologic malignancies and stem cell transplant recipients.
Nguyen MH; Leather H; Clancy CJ; Cline C; Jantz MA; Kulkarni V; Wheat LJ; Wingard JR
Biol Blood Marrow Transplant; 2011 Jul; 17(7):1043-50. PubMed ID: 21087680
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation of risk factors for invasive pulmonary aspergillosis and detection of diagnostic values of galactomannan and PCR methods in bronchoalveolar lavage samples from non-neutropenic intensive care unit patients].
Özger S; Hızel K; Kalkancı A; Aydoğdu M; Civil F; Dizbay M; Gürsel G
Mikrobiyol Bul; 2015 Oct; 49(4):565-75. PubMed ID: 26649414
[TBL] [Abstract][Full Text] [Related]
20. Validation of a new Aspergillus real-time PCR assay for direct detection of Aspergillus and azole resistance of Aspergillus fumigatus on bronchoalveolar lavage fluid.
Chong GL; van de Sande WW; Dingemans GJ; Gaajetaan GR; Vonk AG; Hayette MP; van Tegelen DW; Simons GF; Rijnders BJ
J Clin Microbiol; 2015 Mar; 53(3):868-74. PubMed ID: 25568431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
